Unravelling Potential Mechanisms of Piper retrofractum Vahl. Bioactive Compounds as Cervical Cancer Chemopreventive Agent by Bioinformatic Approach

I Kadek Sindhu Satya Mahindra, I Made Gede Ari Kusuma, Wayan Dianda Sari, Desak Made Dewi Diantari, Priyanka Lestari, I Wayan Martadi Santika

Abstract


Cervical cancer is the leading cause of cancer death after breast cancer. HPV infection is the main cause of cervical cancer which will cause overexpression of E6 oncoprotein. E6 oncogene can cause cancer cells to continue to proliferate. Long pepper fruit (Piper retrofractum Vahl.) has antioxidant activity and contains piperine compounds that have anticancer activity. This study aims to assess the potential of long pepper fruit extract as a chemopreventive agent for cervical cancer. The research method was conducted by in silico assay with network pharmacology and molecular docking analysis. We found five hub genes including HSP90AA1, SRC, AKT1, STAT3, and PIK3CA. KEGG analysis showed that the most dominant signaling pathways involved are neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, MAPK signaling pathway, Calcium signaling pathway, and cAMP signaling pathway. Through molecular docking, it was found that long pepper fruit has the potential to inhibit the E6 oncogene of HPV. Based on the research results, long pepper fruit extract may has the potential as a chemoprevention agent for cervical cancer.

Keywords: Cervical cancer, oncoprotein HPV16-E6, Piper retrofractum Vahl., molecular docking, network pharmacology.


Full Text:

PDF

References


Almeida, A.M., Queiroz, J.A., Sousa, F., and Sousa, Â., 2019, Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins, Drug Discov. Today, 24(10), 2044–2057. CrossRef

Bahrami, A., Hasanzadeh, M., Hassanian, S.M., ShahidSales, S., Ghayour-Mobarhan, M., Ferns, G.A., and Avan, A., 2017a, The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy, J. Cell. Biochem., 118(12), 4163–4169. CrossRef

Bahrami, A., Hasanzadeh, M., Shahid-Sales, S., Yousefi, Z., Kadkhodayan, S., Farazestanian, M., Mashhad, M.J., Gharib, M., Hassanian, S.M, and Avan, A., 2017b, Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer, J. Cell. Biochem., 118(10), 3028–3033. CrossRef

Beaudenon, S., and Huibregtse, J.M., 2008, HPV E6, E6AP and cervical cancer, BMC Biochem, 9(Suppl 1), S4. CrossRef

Buranrat, B., 2022, Anticancer Potential of Piper retrofractum on Breast Cancer MCF-7 Cells Via Induction of Cell Death and Reduction of Cell Migration, Pharmacogn. Mag., 18(79), 532-539. CrossRef

Chen, C.L., Hsieh, F.C., Lieblein, J.C., Brown, J., Chan, C., Wallace, J.A., et al., 2007, Stat3 activation in human endometrial and cervical cancers, British Journal of Cancer, 96, 591–599. CrossRef

Chen, H., Sheng, H., Zhao, Y., Zhu, G., 2020, Piperine inhibits cell proliferation and induces apoptosis of human gastric cancer cells by downregulating phosphatidylinositol 3-kinase (PI3K)/Akt pathway, Med. Sci. Monit., 26, e928403. CrossRef

Cherry, J.J., Rietz, A., Malinkevich, A., Liu, Y., Xie, M., Bartolowits, M., et al., 2013, Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function, PLoS One, 8, 1–21. CrossRef

Chitsike, L., and Duerksen-Hughes, P.J., 2021, PPI modulators of E6 as potential targeted therapeutics for cervical cancer: Progress and challenges in targeting E6, Molecules, 26(10), 3004. CrossRef

Das, R., Agrawal, S., Kumar, P., Singh, A.K., Shukla, P.K., Bhattacharya, I., et al., 2023, Network pharmacology of apigeniflavan: a novel bioactive compound of Trema orientalis Linn. in the treatment of pancreatic cancer through bioinformatics approaches, 3 Biotech, 13(5), 160. CrossRef

Das, S., Babu, A., Medha, T., Ramanathan, G., Mukherjee, A.G., Wanjari, U.R., et al., 2023, Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients, Med. Oncol., 40, 149. CrossRef

Ekowati, H., Achmad, A., Prasasti, E., Wasito, H., Sri, K., Hidayati, Z., and Ekasari, T., 2012, Zingiber officinale, Piper retrofractum and Combination Induced Apoptosis and p53 Expression in Myeloma and WiDr Cell Lines, HAYATI J. Biosci., 19(3), 137–140. CrossRef

Evriarti, P.R., and Yasmon, A., 2019. Patogenesis Human Papillomavirus (HPV) pada Kanker Serviks, J. Biotek Medisiana Indones., 8, 23–32. CrossRef

Fan, G., Tu, Y., Wu, N., and Xiao, H., 2020, The expression profiles and prognostic values of HSPs family members in Head and neck cancer, Cancer Cell Int., 20, 220. CrossRef

Frianto, D., Setiawan, D., Diantini, A., and Suwantika, A.A., 2022, Parental Acceptance of Human Papillomavirus (HPV) Vaccination in Districts with High Prevalence of Cervical Cancer in West Java, Indonesia, Patient Prefer. Adherence, 16, 2709–2720. CrossRef

Health Commission of the PRC, N., 2022, National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version), Chinese J. Cancer Res., 34(3), 256–269. CrossRef

Iksen, I., Witayateeraporn, W., Wirojwongchai, T., Suraphan, C., Pornputtapong, N., Singharajkomron, N., et al., 2023, Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments, Sci. Rep., 13, 1545. CrossRef

Iqbal, J., Abbasi, B.A., Mahmood, T., Kanwal, S., Ali, B., Shah, S.A., and Khalil, A.T., 2017, Plantderived anticancer agents: A green anticancer approach, Asian Pac. J. Trop. Biomed., 7(12), 1129–1150. CrossRef

Kolluru, S., Momoh, R., Lin, L., Mallareddy, J.R., and Krstenansky, J.L., 2019, Identification of potential binding pocket on viral oncoprotein HPV16 E6: A promising anti-cancer target for small molecule drug discovery, BMC Mol. Cell Biol., 20, 30. CrossRef

Kong, L., Deng, Z., Zhao, Y., Wang, Y., Sarkar, F.H., and Zhang, Y., 2011, Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells, Med. Oncol., 28, 1495–1506. CrossRef

Laksmiani, N.P.L., Paramita, N.L.P.V., and Wirasuta, I.M.A.G., 2016, In vitro and in silico antioxidant activity of purified fractions from purple sweet potato ethanolic extract, Int. J. Pharm. Pharm. Sci., 8(8), 177–181.

Lee, H.G., Yu, K.A., Oh, W.K., Baeg, T.W., Oh, H.C., Ahn, J.S., et al., 2005, Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16, J. Ethnopharmacol., 98(3), 339–343. CrossRef

Lee, H.S., Lee, I.H., Kang, K., Park, S.I., Jung, M., Yang, S.G., et al., 2021, A Comprehensive Understanding of the Anticancer Mechanisms of FDY2004 Against Cervical Cancer Based on Network Pharmacology, Nat. Prod. Commun, 16(3). CrossRef

Lipinski, C.A., 2004, Lead- and drug-like compounds: The rule-of-five revolution, Drug Discov. Today Technol., 1(4), 337–341. CrossRef

Liu, Y., Li, X., Zhou, X., Wang, J., and Ao, X., 2022, FADD as a key molecular player in cancer progression, Mol. Med., 28, 132. CrossRef

Manzo-Merino, J., Contreras-Paredes, A., Vázquez-Ulloa, E., Rocha-Zavaleta, L., Fuentes-Gonzalez, A.M., and Lizano, M., 2014, The Role of Signaling Pathways in Cervical Cancer and Molecular Therapeutic Targets, Arch. Med. Res., 45(7), 525–539. CrossRef

Mitra, S., Anand, U., Jha, N.K., Shekhawat, M.S., Saha, S.C., Nongdam, P., et al., 2022, Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic

Perspectives, Front. Pharmacol., 12, 1–19. CrossRef

Pal, A., and Kundu, R., 2020, Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy, Front. Microbiol., 10, 3116. CrossRef

Rasna, I.W., and Tantra, D.K., 2017, Medical Plants in Usadha: Loloh as Balinese Medicine and Traditional Herbal Product in Educational Perspective, in: 2nd International Conference on Innovative Research Across Disciplines (ICIRAD 2017), pp. 189–194. CrossRef

Ricci-López, J., Vidal-Limon, A., Zunñiga, M., Jimènez, V.A., Alderete, J.B., Brizuela, C.A., and Aguila, S., 2019, Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein, PLoS One, 14(3), e0213028. CrossRef

Setiawan, S.D., 2015, The Effect of Chemotherapy in Cancer Patient to Anxiety, J Major, 4, 94–99.

Sidhu, H., Gautam, L.K., and Capalash, N., 2023, Unraveling the molecular mechanism of l-menthol against cervical cancer based on network pharmacology, molecular docking and in vitro analysis, Mol. Divers., 27, 323–340. CrossRef

Soave, C.L., Guerin, T., Liu, J., and Dou, Q.P., 2017, Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing, Cancer Metastasis Rev., 36, 717–736. CrossRef

Soumia, M., Hajji, H., El Mzibri, M., Younes, F.Z., Mohammed, B., Mohamed, B., and Benaissa, M., 2022, In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6

Protein, Vaccines, 10(9), 1452. CrossRef

Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F., 2021, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA. Cancer J. Clin., 71(3), 209–249. CrossRef

Suryadarma, I.G.P., 2010, Keanekaragaman Tumbuhan Bahan Kebugaran Dalam Naskah Lontar Rukmini Tatwa Masyarakat Bali ‘Rukmini Tatwa, a Balinese Script, on the Diversity of Plant Use for Human Body Fitness’, Biota, 15(2), 290-300.

Takiguchi, E., Nishimura, M., Mineda, A., Kawakita, T., Abe, A., and Irahara, M., 2017, Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells, Exp. Ther. Med., 14(5), 4293–4299. CrossRef

Tungteakkhun, S.S., Filippova, M., Neidigh, J.W., Fodor, N., and Duerksen-Hughes, P.J., 2008, The Interaction between Human Papillomavirus Type 16 and FADD Is Mediated by a Novel E6 Binding Domain, J. Virol., 82(19), 9600–9614. CrossRef

Yuan, L., Chen, L., Qian, K., Qian, G., Wu, C.L., Wang, X., and Xiao, Y., 2017, Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC), Genomics Data, 14, 132–140. CrossRef

Zhang, H., Zhang, R., Su, Y., Zheng, J., Li, H., Han, Z., et al., 2023, Anti-cervical cancer mechanism of bioactive compounds from

Alangium platanifolium based on the ‘compound-target-disease’ network, Heliyon, 9(10), e20747. CrossRef

Zhang, P., Li, H., Yang, B., Yang, F., Zhang, L.L., Kong, Q.Y., et al , 2014, Biological significance and therapeutic implication of resveratrolinhibited Wnt, notch and STAT3 signaling in cervical cancer cells, Genes and Cancer, 5(5-6), 154–164. CrossRef

Zhou, J., Li, H., Wu, B., Zhu, L., Huang, Q., Guo, Z., et al., 2024, Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer, Sci. Rep., 14, 1860. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev15iss1pp50-62

Copyright (c) 2024 Indonesian Journal of Cancer Chemoprevention

Indexed by:

                  

               

 

Indonesian Society for Cancer Chemoprevention